Navigation Links
Watson to Present at the UBS Global Specialty and Generic Pharmaceuticals Conference
Date:5/23/2008

CORONA, Calif., May 23 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the UBS Global Specialty and Generic Pharmaceuticals Conference on Wednesday, May 28, 2008 at 2:30 p.m. London BST (9:30 a.m. EDT).

This presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Web site at http://ir.watson.com. The webcast can also be accessed at the following URL: http://events.webeventservices.com/ubs/2008/05/28/index.asp.

An archived version will be available for 30 days after the live presentation and can be accessed at the same locations.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc, headquartered in Corona, California, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes brand and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.

For press releases and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO)


'/>"/>
SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Watson to Present at the Bank of America 2008 Healthcare Conference
2. Texas Senator Kirk Watson Honored as Champion for Children by the AMERIGROUP Foundation
3. Watson Files Application for Generic SEASONIQUE(R)
4. 60 Minutes to Report on Dangers of Trasylol: Cory Watson Crowder & DeGaris Involved in Litigation Against Pharmaceutical Giant Bayer AG
5. Few Employers Addressing Workplace Stress, Watson Wyatt Surveys Find
6. Watson Pharmaceuticals Announces FDA Inspection of Florida Facilities
7. Medical Cost Increases to Accelerate Worldwide Over Next Five Years, Watson Wyatt Poll Finds
8. Watson to Distribute Alendronate Tablets
9. Watson Receives FDA Approval for Generic DuoNeb(R)
10. Watson Confirms Patent Litigation With Barr Related to Seasonale(R)
11. Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...INGTON, Va., Dec. 2 From more than...ive us meaning, joy and peace, the LIFE Foundation...t conducted using the popular photo-sharing Web si... a video montage on the LIFE Foundation,s Web site...ntestants submitted one photo and a caption to Fli...
(Date:12/2/2009)...STOWN, N.J., Dec. 2 Wats...unced that the Federal Trade Commission (FTC) has ...nt relating to Watson,s pending acquisition of pri...ination of the Hart Scott Rodino waiting period, t...tion. The parties have now obtained all regulator...
(Date:12/2/2009)...Advisory for Thursday, Dec. 3 ,, Head of Army... Meeting of Army Wounded Warriors; Army Embraces R... ,, WASHINGTON, Dec. 2 /PRNewswire-USNewswire/ ...l Organization on Disability: ,, WHAT: Wounde...nded Warrior (AW2) program,s National Organization...
(Date:12/2/2009)...NGTON and REDMOND, Wash., Dec. 2 /PRNewswire/ -... companies will collaborate to give caregivers sin...tion necessary for providing ongoing care after pa... their families better tools for managing patients...ute care organization to adopt Microsoft Amalga Un...
(Date:12/2/2009)...STOWN, N.J., Dec. 2 Wats...unced that it has completed the acquisition of Arr...purchase creates a financially strong, global spec...in annual revenues and operations in more than 20 ...enefits to Watson shareholders as a result of this...
Breaking Medicine News(10 mins):Health News:Wonders of Life Photo Contest Winners Announced 2Health News:Wonders of Life Photo Contest Winners Announced 3Health News:Watson Receives FTC Clearance for Arrow Acquisition 2Health News:Wounded Vets, CAREER Counselors Gather in Washington as Obama Announces Afghanistan Troop Buildup 2Health News:Golden Living Kick-Starts Post-Acute Health IT with Microsoft HealthVault and Amalga UIS Connection 2Health News:Golden Living Kick-Starts Post-Acute Health IT with Microsoft HealthVault and Amalga UIS Connection 3Health News:Golden Living Kick-Starts Post-Acute Health IT with Microsoft HealthVault and Amalga UIS Connection 4Health News:Watson Completes Acquisition of Arrow Group 2Health News:Watson Completes Acquisition of Arrow Group 3Health News:Watson Completes Acquisition of Arrow Group 4Health News:Watson Completes Acquisition of Arrow Group 5
...1Q09 Xyrem(R) net sales of $18 million are 56% hig...9 million are 50% lower than 1Q08 , , PALO ALTO, ...q: JAZZ ) today announced financial results for ... 2008. Xyrem(R) (sodium oxybate) oral solution net...
...YL, North Wales, May 7 Glan Clywd Hospital will s... more advanced radiotherapy treatments using Rapid...nt machines from Varian Medical Systems (NYSE: V...form of radiotherapy that extends more advanced ca...
...NVER, May 7 Air Methods Corporation (Nasdaq: AI... What: Air Methods Corporation Webcast, ... Where: http://www.videonewswire.com/event... to participate during the live Webcast, the call,...
...APEL HILL, N.C., May 7 When the unpredictable i...fficials warn that the seemingly lessening threat ...andemic contingency plans already, nearly one-thir... LLC primary research study on "Managing Workforce...
...affirms Full Year 2009 Revenue and Increases Low-e... , First Quarter 2009 Highlights: , , , , ...over-year and up 6.8% on a constant currency basis...of $11.2 million, up 17.2% year-over-year and up 1...
...th Annual Building Safety Week is May 3-9, 2009 ...y Week 2009, the International Code Foundation is ...o save money and prevent disasters. , , (Photo:...e water supply for granted all thanks to the enfor...
Other Medicine News:Health News:Jazz Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results 2Health News:Jazz Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results 3Health News:Jazz Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results 4Health News:Jazz Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results 5Health News:Jazz Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results 6Health News:Cancer Patients in North Wales to Gain Access to Varian's RapidArc Radiotherapy Treatments 2Health News:Corporate Pandemic Preparedness Experts from Roche & PSEG to Advise Savvy Business Leaders May 15 2Health News:Corporate Pandemic Preparedness Experts from Roche & PSEG to Advise Savvy Business Leaders May 15 3Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 2Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 3Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 4Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 5Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 6Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 7Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 8Health News:Daily Dose: Safe Water News You Can Use 2Health News:Daily Dose: Safe Water News You Can Use 3
(Date:12/2/2009)... , NANJING, China, Dec. 2 /PRNewswire-As...the "Company") (NYSE: SCR ), a leading pharmaceu...ufacturing, and marketing of branded,generic and p...d that its,subsidiary Jiangsu Yanshen Biological T...suspended production of all its products in order ...
(Date:12/2/2009)... , EAST HANOVER, N.J., Dec. 2 /PRNewswir...uding a late-breaking presentation on Tasigna®... myeloid leukemia, demonstrate the strength of the...are of patients. ,, The new data, at the 51st ...g and Exposition, highlight the company,s current ...
(Date:12/1/2009)..., TEMECULA, Calif., Dec. 1 /PRNewswire-FirstCal...tin Board: PSTX) announced today that it has appoi...ef Financial Officer, Treasurer and Corporate Secr...CFO since 2008. Prior to joining Patient Safety T...ance, Chief Financial Officer, Treasurer and Corpo...
Breaking Medicine Technology:Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 2Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Patient Safety Technologies, Inc. Appoints Marc L. Rose, CPA (PA), Chief Financial Officer 2Live Broadcast of Drug Rehab Graduation at Canadian Narconon 50339 1Live Broadcast of Drug Rehab Graduation at Canadian Narconon 50339 2BioSpecifics Technologies Corp Added to Russell 3000 and Russell 2000 Indexes 12832 1BioSpecifics Technologies Corp Added to Russell 3000 and Russell 2000 Indexes 12832 2Depression Anxiety Bad for the Heart 50336 1Depression Anxiety Bad for the Heart 50336 2Depression Anxiety Bad for the Heart 50336 3
CKX41 Inverted Laboratory System Microscope
Eclipse TE2000U
IX71 Inverted Research Microscope
...clipse TS-100 is an innovative and efficient inver...plements any research facility. , ,Outstanding Op...harp images in all magnifications. Objectives deli...n and contrast, chromatic aberration free correcti...
Medicine Products: